
    
      This is a prospective, multicenter, non-blinded, non-randomized study of the RelayPro
      Thoracic Stent-Graft in subjects with traumatic injury of the DTA in subjects who are
      candidates for endovascular repair.The primary objective of the study is all-cause mortality
      at 30 days post procedure.

      The secondary objectives of the trial will include descriptive analyses of procedural and
      post-procedural observations through 5 years of follow-up.
    
  